Andreas Rohringer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Rohringer has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Bjørnar Ytrehus
Norwegian Veterinary Institute, Ås, Norway
2 shared publications - Britt Gjerset
Norwegian Veterinary Institute, Ås, Norway
2 shared publications - Cathrine Arnason Bøe
Norwegian Veterinary Institute Ås Norway
2 shared publications - Lamprini Veneti
Department of Infection Control and Preparedness, Norwegian Institute of Public Health
2 shared publications - Ragnhild Tønnessen
Norwegian Veterinary Institute Ås Norway
2 shared publications - Anke Stüken
Microbial Evolution Research Group (MERG), Department of Biology, University of Oslo, Oslo, Norway
1 shared publication
Latest Publications
- Open Access
Highly Pathogenic Avian Influenza Viruses H5N1 and H5N5 in Red Foxes ( Vulpes vulpes ) in Norway during 2022-2024
Since 2020, highly pathogenic avian influenza (HPAI) A(H5Nx) clade 2.3.4.4b viruses have spread globally, causing extensive outbreaks in domestic and wild birds. Increased circulation has resulted in frequent spillover to mammals, and occasional mammal-to-mammal transmission. Although human infections remain rare, the zoonotic potential of these viruses continues to be a public health concern. We investigated six cases of HPAI in red foxes ( Vulpes vulpes ) in Norway during 2022-2024 and identified infections with H5N1 and H5N5 viruses. Pathological and virological investigations demonstrated systemic infection, with prominent lesions in the brain and/or lungs. Phylogenetic analyses showed high similarity between viruses detected in foxes and those concurrently circulating in wild birds. The mammalian adaptation marker PB2:E627K was identified in one H5N1 virus and as a minority variant in a second H5N1 virus.
Open AccessHighly Pathogenic Avian Influenza Viruses H5N1 and H5N5 in Red Foxes ( Vulpes vulpes ) in Norway during 2022-2024
Since 2020, highly pathogenic avian influenza (HPAI) A(H5Nx) clade 2.3.4.4b viruses have spread globally, causing extensive outbreaks in domestic and wild birds. Increased circulation has resulted in frequent spillover to mammals, and occasional mammal-to-mammal transmission. Although human infections remain rare, the zoonotic potential of these viruses continues to be a public health concern. We investigated six cases of HPAI in red foxes ( Vulpes vulpes ) in Norway during 2022-2024 and identified infections with H5N1 and H5N5 viruses. Pathological and virological investigations demonstrated systemic infection, with prominent lesions in the brain and/or lungs. Phylogenetic analyses showed high similarity between viruses detected in foxes and those concurrently circulating in wild birds. The mammalian adaptation marker PB2:E627K was identified in one H5N1 virus and as a minority variant in a second H5N1 virus.
- Open Access
Highly Pathogenic Avian Influenza H5N5 in a Polar Bear and Atlantic Walrus, Svalbard, 2026, with Widespread Seroconversion in Polar Bears
Highly pathogenic avian influenza virus (HPAIV) subtype H5N5 was detected in a one-year-old polar bear ( Ursus maritimus ) and an adjacent adult Atlantic walrus ( Odobenus rosmarus rosmarus ), both found deceased in Raudfjorden, Svalbard. This represents the first confirmed case of HPAI in a European polar bear and the second in an Atlantic walrus. Viral genomes were nearly identical and harbored PB2-E627V, a marker associated with mammalian adaptation. Several polar bears, including the deceased individual, had previously been observed feeding on the walrus carcass. Antibodies against H5 were detected in 75% of polar bears in 2023 (n=36) and 97% in 2024-2025 (n=65), suggesting extensive circulation of HPAIV in the population following the first detections in birds in Svalbard in 2022, whereas no antibodies were detected in samples from 2014-2022 (n=243).
Open AccessHighly Pathogenic Avian Influenza H5N5 in a Polar Bear and Atlantic Walrus, Svalbard, 2026, with Widespread Seroconversion in Polar Bears
Highly pathogenic avian influenza virus (HPAIV) subtype H5N5 was detected in a one-year-old polar bear ( Ursus maritimus ) and an adjacent adult Atlantic walrus ( Odobenus rosmarus rosmarus ), both found deceased in Raudfjorden, Svalbard. This represents the first confirmed case of HPAI in a European polar bear and the second in an Atlantic walrus. Viral genomes were nearly identical and harbored PB2-E627V, a marker associated with mammalian adaptation. Several polar bears, including the deceased individual, had previously been observed feeding on the walrus carcass. Antibodies against H5 were detected in 75% of polar bears in 2023 (n=36) and 97% in 2024-2025 (n=65), suggesting extensive circulation of HPAIV in the population following the first detections in birds in Svalbard in 2022, whereas no antibodies were detected in samples from 2014-2022 (n=243).
- Open Access
- 10 January 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 182, 105912
A series of diagnostic contamination events from seasonal influenza vaccines
- 10 January 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 182, 105912
Open AccessA series of diagnostic contamination events from seasonal influenza vaccines
- Open Access
- 27 May 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 44 (9) , 2047-2057
Risk factors associated with long-term shedding infections of non-typhoidal Salmonella in humans
Purpose: Non-typhoidal Salmonella (NTS) gastroenteritis in humans is typically self-limited, resolving within 48–72 h. However, some infections result in a carrier state characterised by persistent gut colonisation and long-term shedding (LTS). This study aimed to investigate risk factors associated with LTS of NTS in humans. Methods: Salmonellosis cases reported to the Norwegian surveillance system in 2019 were invited to participate. Participants submitted a follow-up stool sample and a questionnaire five weeks after initial sampling (detecting infection). Stool samples were cultured, and isolates were sequenced to determine genotype, serotype and antimicrobial resistance genotype. NTS cases were classified as LTS if the isolates from both samples differed by ≤ 5 alleles. Adjusted odds ratios (aORs) with 95% confidence intervals (95%CIs) were calculated using logistic regression to investigate potential risk factors associated with LTS. Results: Of 1,094 reported cases, 255 (23%) with NTS participated; 24% were classified as LTS. Children aged 0–5 years were 6.7 times more likely to exhibit LTS compared to adults aged 18–44 years (aOR = 6.71, 95%CI:1.67–26.94). Participants who received regular medication and those following a lactose-free diet were 2.2 (aOR = 2.17, 95%CI:1.02–4.64) and 7.2 (aOR = 7.24, 95%CI:1.48–35.40) times more likely to exhibit LTS than those who did not, respectively. Participants with S. Agbeni or S. Bron were 6 times more likely to exhibit LTS compared to S. Typhimurium cases (aOR = 6.29, 95%CI:1.40–28.16). Conclusions: Observed risk factors associated with LTS included young age, regular medication use, lactose-free diet, and specific Salmonella serotypes. Further research is needed to increase knowledge regarding LTS and inform infection control measures.
- 27 May 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 44 (9) , 2047-2057
Open AccessRisk factors associated with long-term shedding infections of non-typhoidal Salmonella in humans
Purpose: Non-typhoidal Salmonella (NTS) gastroenteritis in humans is typically self-limited, resolving within 48–72 h. However, some infections result in a carrier state characterised by persistent gut colonisation and long-term shedding (LTS). This study aimed to investigate risk factors associated with LTS of NTS in humans. Methods: Salmonellosis cases reported to the Norwegian surveillance system in 2019 were invited to participate. Participants submitted a follow-up stool sample and a questionnaire five weeks after initial sampling (detecting infection). Stool samples were cultured, and isolates were sequenced to determine genotype, serotype and antimicrobial resistance genotype. NTS cases were classified as LTS if the isolates from both samples differed by ≤ 5 alleles. Adjusted odds ratios (aORs) with 95% confidence intervals (95%CIs) were calculated using logistic regression to investigate potential risk factors associated with LTS. Results: Of 1,094 reported cases, 255 (23%) with NTS participated; 24% were classified as LTS. Children aged 0–5 years were 6.7 times more likely to exhibit LTS compared to adults aged 18–44 years (aOR = 6.71, 95%CI:1.67–26.94). Participants who received regular medication and those following a lactose-free diet were 2.2 (aOR = 2.17, 95%CI:1.02–4.64) and 7.2 (aOR = 7.24, 95%CI:1.48–35.40) times more likely to exhibit LTS than those who did not, respectively. Participants with S. Agbeni or S. Bron were 6 times more likely to exhibit LTS compared to S. Typhimurium cases (aOR = 6.29, 95%CI:1.40–28.16). Conclusions: Observed risk factors associated with LTS included young age, regular medication use, lactose-free diet, and specific Salmonella serotypes. Further research is needed to increase knowledge regarding LTS and inform infection control measures.